Fraser Clift - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Fraser Clift

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Comparative Effectiveness Research|August 22, 2023

Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in CanadaVirender Bhan, Fraser Clift, Moogeh Baharnoori, et al.

Multiple Sclerosis and Related Disorders|May 18, 2021

Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosisStephanie N Blandford, Dylan A Galloway, John B Williams, et al.

Frontiers in Stroke|January 16, 2026

Improving access and efficiency of ischemic stroke treatment across four Canadian provinces using a stepped wedge trial: MethodologyNoreen Kamal, Shadi Aljendi, Alix Carter, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Comparative Effectiveness Research|August 22, 2023

Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in CanadaVirender Bhan, Fraser Clift, Moogeh Baharnoori, et al.

Multiple Sclerosis and Related Disorders|May 18, 2021

Frontiers in Stroke|January 16, 2026

Improving access and efficiency of ischemic stroke treatment across four Canadian provinces using a stepped wedge trial: MethodologyNoreen Kamal, Shadi Aljendi, Alix Carter, et al.

Pageof 2